New Oral Pill for Postpartum Depression Treatment Set for December Release, with an Estimated Cost of $16,000
Zurzuvae, the recently FDA-approved pill to treat postpartum depression. (Image: Getty; illustration by Alex Cochran for Yahoo) (Illustration by Alex Cochran for Yahoo ; Photo: Getty Images) In August the Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication to treat postpartum depression. The approval is a big step for women with the …